文献速递妇产影像心血管外周血管US

妊娠中期发生妊娠期糖尿病和妊娠期高血压疾病女性的心血管表型:比较研究

Midgestation cardiovascular phenotype in women who develop gestational diabetes and hypertensive disorders of pregnancy: comparative study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-01

该前瞻性观察研究在5214例妊娠19+1至23+3周孕妇中行超声心动图、眼动脉多普勒、子宫动脉搏动指数及胎盘生长因子检测,发现后续发生妊娠期高血压疾病者胎盘灌注受损且外周血流阻抗指标一致升高,而单纯妊娠期糖尿病者胎盘功能正常、外周阻抗仅轻度增加或与正常无显著差异,两组均有左心室功能亚临床轻度减低。

要点

  • 妊娠中期眼动脉收缩期峰值流速比值升高及超声心动图外周血管阻力增加,在后续发生妊娠期高血压疾病者中一致出现。
  • 单纯妊娠期糖尿病孕妇胎盘生长因子正常,眼动脉收缩期峰值流速比值与正常组无显著差异。
  • 妊娠期高血压疾病组与妊娠期糖尿病组均可出现整体纵向收缩期应变升高,提示左心室功能亚临床轻度减低。

核心结论

  • 妊娠中期后续发生妊娠期高血压疾病或妊娠期糖尿病女性存在左心室功能轻度亚临床减低;妊娠期高血压疾病者(无论是否合并妊娠期糖尿病)有胎盘植入受损证据且外周血流阻抗指标一致升高,而单纯妊娠期糖尿病者胎盘功能正常、外周血流阻抗指标仅轻度升高或与正常无显著差异。

研究设计与样本

  • 前瞻性观察研究,纳入妊娠19+1至23+3周行常规医院检查的5214例孕妇,评估眼动脉血流速度波形、超声心动图母体心血管功能、子宫动脉搏动指数及血清胎盘生长因子,指标经母体特征和病史调整后转换为中位数倍数或中位数偏差值。

诊断标准与关键数值

  • 共5214例妊娠,其中未受妊娠期糖尿病或妊娠期高血压疾病影响4429例(84.9%)、单纯妊娠期糖尿病509例(9.8%)、妊娠期糖尿病合并妊娠期高血压疾病41例(0.8%)、单纯妊娠期高血压疾病235例(4.5%);组间生物标志物中位数偏差或中位数倍数采用95%CI和t检验比较。

临床应用与阅片要点

  • 妊娠中期超声评估时,眼动脉收缩期峰值流速比值升高、超声心动图外周血管阻力增加及平均动脉压升高一致见于后续发生妊娠期高血压疾病者,无论是否合并妊娠期糖尿病;单纯妊娠期糖尿病者上述外周阻抗指标仅轻度升高或与正常无显著差异,胎盘生长因子正常。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Women with gestational diabetes mellitus (GDM) and/or hypertensive disorders of pregnancy (HDP) are at increased long-term cardiovascular risk. Mild cardiac functional alterations have been detected in women with GDM or HDP in midgestation, prior to clinical onset of the disease, but these functional alterations have not been found to be useful as screening tools. In contrast, increased impedance to peripheral blood flow, measured by echocardiography or ophthalmic artery Doppler, has been shown to provide incremental value to maternal characteristics for the prediction of pre-eclampsia. However, it is unknown whether similar changes can be detected in women at risk of GDM. In this study, we performed detailed cardiovascular phenotyping in a large, unselected population of women in midgestation to identify similarities and differences in cardiovascular adaptation in women who are at risk of GDM and/or HDP.

METHODS: This was a prospective observational study in women attending for a routine hospital visit at 19 + 1 to 23 + 3 weeks' gestation. This visit included assessment of flow velocity waveforms from the maternal ophthalmic arteries, echocardiography for assessment of maternal cardiovascular function and measurement of uterine artery pulsatility index and serum placental growth factor (PlGF) for assessment of placental perfusion and function. The measured indices were converted to either multiples of the median (MoM) values or deviation from the median (delta) after adjusting for maternal characteristics and elements of medical history. Biomarker delta or MoM values in the GDM and HDP groups were compared with those in the unaffected group using 95% CI and t-tests.

RESULTS: The study population of 5214 pregnancies contained 4429 (84.9%) that were unaffected by GDM or HDP, 509 (9.8%) complicated by GDM without HDP, 41 (0.8%) with GDM and HDP, and 235 (4.5%) with HDP without GDM. In HDP cases, with or without GDM, there was evidence of impaired placentation, with a decrease in PlGF, and increased impedance to flow in the peripheral circulation, suggested by an increase in ophthalmic artery peak systolic velocity (PSV) ratio, peripheral vascular resistance assessed on echocardiography and mean arterial pressure. In the GDM group without HDP, there was no evidence of altered placental perfusion or function and ophthalmic artery PSV ratio was not significantly different from that in the unaffected group; peripheral vascular resistance and mean arterial pressure were increased but to a lesser degree than in the HDP group. In the HDP group, there was an increase in global longitudinal systolic strain and slight increase in isovolumic relaxation time, while in the GDM group, there was an increase in mitral valve E/e', myocardial performance index and global longitudinal systolic strain.

CONCLUSIONS: In midgestation, women who subsequently develop HDP or GDM have a mild subclinical reduction in left ventricular function. In HDP cases, with or without GDM, there is evidence of impaired placentation and all biomarkers of impedance to peripheral blood flow are consistently increased. In contrast, in the GDM group without HDP, biomarkers of placental function are normal and those of impedance to peripheral blood flow are either marginally increased or not significantly different from those in normal pregnancies. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Anzoategui S, Gibbone E, Wright A, et al. Midgestation cardiovascular phenotype in women who develop gestational diabetes and hypertensive disorders of pregnancy: comparative study. Ultrasound Obstet Gynecol. 2022. PMID: 35502146. doi:10.1002/uog.24929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。